MICHAEL MILES: Open Payments
NPI 1760458319 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 18 payments from 10 companies in 2025. Trend: 2023 $76 · 2024 $66 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $103 |
| Abbott Laboratories | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
| Amgen Inc. | 2 | $30 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Wegovy, FREESTYLE LIBRE 3, CAPLYTA, SHINGRIX, Cologuard Collection Kit, OTEZLA, PREVNAR 20, JARDIANCE.
Industry payments across GA — which companies pay providers there.
